Featured Research

from universities, journals, and other organizations

National Jewish Pediatric Asthma Specialist Urges Monitoring Growth When Using Nebulized Glucocorticoids As An Asthma Treatment In Children

Date:
November 12, 1998
Source:
National Jewish Medical And Research Center
Summary:
Using a nebulizer as a delivery system for glucocorticoid medication is effective in treating asthma in children, but a National Jewish Medical and Research Center physician recommends continued caution in using the medication because of the drug’s possible impact on a child’s growth.

DENVER -- Using a nebulizer as a delivery system for glucocorticoid medication is effective in treating asthma in children, but a National Jewish Medical and Research Center physician recommends continued caution in using the medication because of the drug’s possible impact on a child’s growth.

Related Articles


For the past 10 years, physicians in the United States have anticipated a Food and Drug Administration-approved glucocorticoid in a nebulized version for children five and younger. (It’s been available in Europe for the past several years.) Currently, inhalers are the main way to deliver the medication. Because inhalers are difficult for a child to control, only a very small amount of the drug reaches the lungs. “It’s a challenge for children less than three years old,” says Stanley J. Szefler, M.D., director of Clinical Pharmacology at National Jewish.

Dr. Szefler’s editorial accompanies an article about a new glucocorticoid clinical trial, which appears in the November issue of the Journal of Allergy and Clinical Immunology. The editorial suggests physicians continue to use caution when prescribing a glucocorticoid for a child, especially those under 5 years old, because long-term use, especially with high doses, can suppress growth.

“The movement is to support early diagnosis and intervention of asthma,” says Dr. Szefler, who is a member of the Food and Drug Administration Pulmonary-Allergy Drug Advisory Committee. “More information is becoming available for the safe and effective use of inhaled steroids in younger children. In older children and adults, inhaled steroids are recognized as the preferred method for long-term asthma control.”

The newly-published study is one of only a few that have probed the safety and effectiveness of using a nebulizer, a device that suspends medication in a mist that is breathed through a mask, for the delivery of glucocorticoids in children. Glucocorticoids, or corticosteroids, reduce inflammation in the lungs.

National Jewish Medical and Research Center is ranked as the best hospital in the United States for pulmonary disease treatment by U.S. News & World Report, 1998.


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "National Jewish Pediatric Asthma Specialist Urges Monitoring Growth When Using Nebulized Glucocorticoids As An Asthma Treatment In Children." ScienceDaily. ScienceDaily, 12 November 1998. <www.sciencedaily.com/releases/1998/11/981111115718.htm>.
National Jewish Medical And Research Center. (1998, November 12). National Jewish Pediatric Asthma Specialist Urges Monitoring Growth When Using Nebulized Glucocorticoids As An Asthma Treatment In Children. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/1998/11/981111115718.htm
National Jewish Medical And Research Center. "National Jewish Pediatric Asthma Specialist Urges Monitoring Growth When Using Nebulized Glucocorticoids As An Asthma Treatment In Children." ScienceDaily. www.sciencedaily.com/releases/1998/11/981111115718.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Suicide Rates Up For Young Women In U.S.

Suicide Rates Up For Young Women In U.S.

Newsy (Mar. 6, 2015) According to a report from the CDC, suicide rates among young women increased from 1994 to 2012 while rates among young men have decreased. Video provided by Newsy
Powered by NewsLook.com
Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins